Safety and Efficacy of Obinutuzumab Alone or with Chemotherapy in Previously Untreated or Relapsed/refractory Chronic Lymphocytic Leukaemia Patients: Final Analysis of the Phase IIIb GREEN Study.
British Journal of Haematology（2021）
Key words
Obinutuzumab,chronic lymphocytic leukaemia,safety,IGHV,minimal residual disease
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined